Profile picture

Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Dyslipidaemia management: a moving target!
Session
Dyslipidaemia management: a moving target!
8 April 2022
Read more
Add on to take back control: Combining lipid lowering therapies for the management of high risk patients
Session
Add on to take back control: Combining lipid lowering therapies for the management of high risk patients
31 August 2020
Read more
Beyond statins - Evolving concepts for the management of dyslipidaemia
Session
Beyond statins - Evolving concepts for the management of dyslipidaemia
1 September 2019
Read more
PCSK9i, changing practice in cardiology: the emerging story
Session
PCSK9i, changing practice in cardiology: the emerging story
31 August 2019
Read more
Meet the Trialists - HPS3/TIMI55-REVEAL
Session
Meet the Trialists - HPS3/TIMI55-REVEAL
29 August 2017
Read more
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention
Session
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention
27 August 2017
Read more
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention
Session
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention
27 August 2017
Read more
Triglycerides and cardiovascular risk: the importance of treating hypertriglyceridaemia
Session
Triglycerides and cardiovascular risk: the importance of treating hypertriglyceridaemia
2 September 2014
Read more

ESC 365 is supported by

novartis Explore sponsored resources